Molecular Pathways: Mitogen-Activated Protein Kinase Pathway Mutations and Drug Resistance

Medicine and Dentistry

• extracellular signal regulated kinase 100%
• Drug Resistance 100%
• Combination Therapy 50%
• Clinical Trial 50%
• Mortality Rate 25%
• Malignant Neoplasm 25%
• Receptor 25%
• Ligation 25%
• Solid Malignant Neoplasm 25%
• Cancer Types 25%
• Overall Survival 25%
• Progression Free Survival 25%
• Hematologic Malignancy 25%
• Salicylate Sodium 25%
• Specific Tumor 25%
• Protein Tyrosine Kinase 25%
• Kinase Signaling 25%
• Tumor 25%
• Next Generation Sequencing 25%
• Melanoma 25%
• Colorectal Carcinoma 25%
• Drug Delivery System 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Drug Resistance 100%
• Mitogen Activated Protein Kinase 100%
• Clinical Trial 50%
• Malignant Neoplasm 50%
• Combination Therapy 50%
• Drug Delivery System 25%
• Melanoma 25%
• Neoplasm 25%
• Receptor 25%
• Solid Malignant Neoplasm 25%
• Mortality Rate 25%
• Progression Free Survival 25%
• Hematologic Malignancy 25%
• Protein Tyrosine Kinase 25%
• Overall Survival 25%
• Salicylate Sodium 25%
• Colorectal Carcinoma 25%

Biochemistry, Genetics and Molecular Biology

• extracellular signal regulated kinase 100%
• Drug Resistance 100%
• Clinical Trial 50%
• Next Generation Sequencing 25%
• Isoform 25%
• Genetic Architecture 25%
• Receptor Tyrosine Kinase 25%
• Mortality Rate 25%
• Drug Targeting 25%
• Progression Free Survival 25%
• Overall Survival 25%
• Transmembrane Protein 25%